Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The mechanism of action of repaglinide involves promoting insulin release from β-islet cells of the pancreas
hippocampus
Pages 1018–1022
BFH772 at 3 mg/kg orally dosed once per day potently inhibits melanoma growth (by 54-90% for primary tumor and 71-96% for metastasis growth) as depicted by treatment to control ratios
Beta-Amyloid(1-14)
BMS-309403 Catalog No.:M20293-C The mechanism of action ofBMS 309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS 309403 interacts with the fatty acid binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS 309403 improves endothelial function in apolipoprotein E deficient mice and in cultured human
US$ 184.00
US$ 38.00
US$ 29.99
US$ 40.00
US$ 164.00